Pheon Therapeutics
PrivateLast Round
Series B
May 21, 2024
Total Funding Raised
$188M
Company Overview
Pheon Therapeutics is a biotechnology company developing next-generation antibody-drug conjugates (ADCs) for a wide range of hard-to-treat cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pheon Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Pheon Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 21, 2024 | ||||
| Series A | Mar 1, 2022 |
Pheon Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Abio-X | Series B |
| Forbion Capital Partners | Series B, Series A |
| TCG Crossover | Series B |
| Research Corporation Technologies | Series B, Series A |
| Perceptive Advisors | Series B |
| RCT | Series B |
| BVF Partners L.P. | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 30, 2026
Developing new cdcp1-targeting antibody-drug conjugates (ADCs).
Pheon Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pheon Therapeutics's valuation, stock price, and market status.
